AstraZeneca UK Limited

Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU
Telephone: +44 (0)1582 836 000
Fax: +44 (0)1582 838 000
Medical Information Direct Line: +44 (0)1582 836 836
Medical Information e-mail: medical.informationuk@astrazeneca.com
Customer Care direct line: +44 (0)1582 837 837
Medical Information Fax: +44 (0)1582 838 003
Patient Information Leaflet last updated on the eMC: 08/04/2009
PIL Zestril 2.5mg, 5mg,10mg, and 20mg tablets.

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 08/04/2009 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
Updated on 21/11/2008 and displayed until 08/04/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 05/06/2008 and displayed until 21/11/2008
Reasons for adding or updating:
  • Change to storage instructions
Updated on 29/06/2007 and displayed until 05/06/2008
Reasons for adding or updating:
  • Addition of Marketing Authorisation Holder
Updated on 18/08/2005 and displayed until 29/06/2007
Reasons for adding or updating:
  • Change to date of revision
  • Correction of spelling/typing errors
Updated on 19/07/2004 and displayed until 18/08/2005
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 06/11/2002 and displayed until 19/07/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 26/09/2002 and displayed until 06/11/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 14/09/2000 and displayed until 26/09/2002
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   lisinopril dihydrate


© 2009 Datapharm Communications Ltd

Go to www.medicines.org.uk